Purpose: Tumor-infiltrating lymphocytes (TIL), in particular CD8+ T cells and CD20+ B cells,
are strongly associated with survival in ovarian cancer and other carcinomas. Although …

Background: The presence of CD8+ tumor-infiltrating lymphocytes (TIL) is associated with
prolonged survival in high-grade serous ovarian cancer (HGSC) and other epithelial …

Purpose: Tumor-infiltrating lymphocytes (TIL) are strongly associated with survival in most
cancers; however, the tumor-reactive subset that drives this prognostic effect remains poorly …

Though therapy that promotes anti-tumor response about CD8+ tumor-infiltrating
lymphocytes (TILs) has shown great potential, clinical responses to CD8+ TILs …

Abstract CD103+ tumor-infiltrating lymphocytes (TIL) have been linked to specific epithelial
infiltration and a prolonged survival in high-grade serous epithelial ovarian cancer (HGSC) …

In a recent report,[Zhang et al.(2003) N. Engl. J. Med. 348, 203–213], the presence of CD3+
tumor-infiltrating lymphocytes (TILs) was found to correlate with improved survival in …

Abstract αE (CD103) β7 is a TGFβ-regulated integrin that mediates retention of lymphocytes
in peripheral tissues by binding to E-cadherin expressed on epithelial cells. We recently …

The accumulation of tumor-specific CD4+ and CD8+ effector T cells is key to an effective
antitumor response. Locally, CD4+ T cells promote the recruitment and effector function of …

Identifying tumor antigen-specific T cells from cancer patients has important implications for
immunotherapy diagnostics and therapeutics. Here, we show that CD103+ CD39+ tumor …

In our study, we investigated the role of CD39 on tumor‐infiltrating CD8+ T lymphocytes
(CD8+ TILs) in colorectal, head and neck and pancreatic cancers. Partially confirming recent …